Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca Drug Interactions
Currently displaying a list of 81 drugs known to interact with Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca (parenteral nutrition solution w/electrolytes).
- 27 major drug interactions
- 40 moderate drug interactions
- 14 minor drug interactions
Medications known to interact with Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca
Note: Showing generic names only.
A
B
C
D
E
F
I
- indium oxyquinoline in-111
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- irbesartan
- isradipine
L
M
- magnesium amino acids chelate
- magnesium aspartate
- magnesium carbonate
- magnesium chloride
- magnesium citrate
- magnesium gluconate
- magnesium glycinate
- magnesium hydroxide
- magnesium lactate
- magnesium malate
- magnesium oxide
- magnesium salicylate
- magnesium sulfate
- magnesium taurate
- magnesium threonate
- mibefradil
- mivacurium
- moexipril
N
O
P
Q
R
S
T
V
Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca disease interactions
There is 1 disease interaction with Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca (parenteral nutrition solution w/electrolytes) which include:
More about Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca (parenteral nutrition solution w/electrolytes)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.